Key result
Comorbid insulin resistance and insomnia linked to ~39% higher risk of incident hypertension.
Why the study?
Insulin resistance and insomnia are both linked to cardiovascular and metabolic problems, but it remained unclear whether insomnia modifies the relationship between insulin resistance and incident hypertension in Hispanic/Latino adults.
Does insomnia modify the association between insulin resistance and 6-year incident hypertension in Hispanic/Latino adults?
Cohort (n=3,300)
Single-blind
Yes
Does insomnia modify the association between insulin resistance and 6-year incident hypertension in Hispanic/Latino adults?
In Hispanic/Latino adults, insulin resistance is associated with a 60% higher 6-year risk of incident hypertension only when comorbid with insomnia, identifying a specific high-risk subgroup for hypertension prevention.
Answers are grounded in this paper and cite their sources.
May identify high-risk Hispanic/Latino adults for hypertension prevention; leaves open causal effects and targeted interventions.
Purpose: We aimed to explore whether insomnia modifies the relationship between insulin resistance (IR) and incident hypertension (HTN) over a 6-year longitudinal period. Methods: To explore the longitudinal relationship between IR, insomnia, and HTN, we included data from 3300 participants over a 6-year follow-up period in a large Hispanic/Latino cohort. IR was defined using the Youden index to select the optimal homeostasis model assessment of insulin resistance cut‑point based on ROC curve analysis, while insomnia was assessed using the Women’s Health Initiative Insomnia Rating Scale. Cox regression analysis was performed to assess the relationship between IR, insomnia and incident HTN. Results: We found neither IR nor insomnia alone was associated with incident HTN, whereas IR combined with insomnia increased the risk of HTN by 39% (HR, 1.39; 95% CI, 1.05– 1.85) after adjustment for potential confounders. Meanwhile, a significant interaction between IR and insomnia was observed (P = 0.045). Post-estimation linear combination analyses showed that IR was associated with a 60% higher risk of incident HTN among participants with insomnia (HR, 1.60; 95% CI, 1.16– 2.21), but not among those without insomnia. Moreover, this synergistic association was significantly associated with incident HTN among men and participants younger than 42 years. Conclusion: This large, longitudinal study identified a significant longitudinal relationship that IR was associated with a higher HTN risk only among participants with insomnia, suggesting that coexisting insomnia may identify a subgroup particularly susceptible to hypertension. Plain Language Summary: Insulin resistance occurs when the body does not respond effectively to insulin and may increase the likelihood of developing high blood pressure. Insomnia has also been linked to cardiovascular and metabolic problems, but it remains unclear whether insomnia makes people with insulin resistance more susceptible to hypertension. We analyzed data from 3,300 Hispanic and Latino adults who were followed for approximately 6 years. Insulin resistance alone was not associated with a significantly higher risk of hypertension. However, among participants with insomnia, insulin resistance was associated with a 60% higher risk of developing hypertension. These findings suggest that people with both insulin resistance and insomnia may represent a subgroup at increased risk of hypertension. Further studies are needed to confirm these findings and determine whether improving sleep can help reduce this risk.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) conducted a cohort in Incident hypertension in relation to insulin resistance and insomnia (n=3,300). Comorbid insulin resistance (HOMA-IR ≥1.77) and insomnia (WHIIRS ≥9) vs. Neither insulin resistance nor insomnia was evaluated on 6-year incident hypertension (SBP ≥140 mmHg, DBP ≥90 mmHg, or self-reported antihypertensive medication use) (HR 1.39, 95% CI 1.05-1.85, p=<0.05). Comorbid insulin resistance and insomnia increased 6-year incident hypertension risk by 39% (HR 1.39, 95% CI 1.05-1.85), with insulin resistance raising risk by 60% (HR 1.60) in those with insomnia.
Synapse has enriched 10 related papers. Consider them for comparative context: